COVID-19 has had a devastating impact on Black, Hispanic, and other underserved, disadvantaged populations. Here anti-SARS-CoV-2 tests are characterized in disadvantaged patients to examine equivalence in US populations. The recently published findings from the MRCIS study clearly demonstrate that despite concerns and mistrust from certain communities, antibody tests for detecting SARS-CoV-2 infection do not discriminate by race/ethnicity and age.

View the Fact Sheet.